Beonghoon Sohn1, Yoomin Kwon1, Seung-Bum Ryoo2,3, Inho Song1, Yoon-Hye Kwon1, Dong Woon Lee1, Sang Hui Moon1, Ji Won Park1,4,5, Seung-Yong Jeong1,4,5, Kyu Joo Park1,4. 1. Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro (28 Yeongeon-dong), Jongno-Gu, Seoul, 03080, Korea. 2. Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro (28 Yeongeon-dong), Jongno-Gu, Seoul, 03080, Korea. sbryoomd@gmail.com. 3. Colorectal Cancer Center, Seoul National University Cancer Hospital, Seoul, 03080, Korea. sbryoomd@gmail.com. 4. Colorectal Cancer Center, Seoul National University Cancer Hospital, Seoul, 03080, Korea. 5. Cancer Research Institute, Seoul National University, Seoul, 03080, Korea.
Abstract
INTRODUCTION: Neuroendocrine tumors have malignant potential, and lymph node metastasis can occur. This study aimed to identify predictive factors of lymph node metastasis and prognostic factors for survival in rectal neuroendocrine tumors. METHODS: Sixty-four patients underwent endoscopic or surgical treatment for rectal NET. The data on these patients were collected in our database prospectively and reviewed retrospectively. RESULTS: Transanal excision was performed in 28 (43.8%) patients, endoscopic mucosal resection or submucosal dissection was performed in 15 (23.4%) patients, and radical resection was performed in 21 (31.8%) patients. Lymph node and distant metastasis was present in 16 (25.0%) and fir (7.8%) patients. The significant risk factors for lymph node metastasis identified in the multivariable analyses were tumor size (≥ 2 cm, p = 0.003) and tumor grade (G2, p < 0.001; G3, p = 0.008). In patients with a tumor smaller than 2 cm, the risk factors for lymph node metastasis included the tumor grade, mitosis count, and Ki-67 index. The median follow-up period was 30.0 months, and recurrence developed in four (6.8%) patients. The significant prognostic factors for survival included tumor size, T stage, lymph node metastasis, and tumor grade. CONCLUSION: Tumor grade combined with tumor size is an important predictive factor for lymph node metastasis and could serve as a prognostic factor for survival outcomes.
INTRODUCTION:Neuroendocrine tumors have malignant potential, and lymph node metastasis can occur. This study aimed to identify predictive factors of lymph node metastasis and prognostic factors for survival in rectal neuroendocrine tumors. METHODS: Sixty-four patients underwent endoscopic or surgical treatment for rectal NET. The data on these patients were collected in our database prospectively and reviewed retrospectively. RESULTS: Transanal excision was performed in 28 (43.8%) patients, endoscopic mucosal resection or submucosal dissection was performed in 15 (23.4%) patients, and radical resection was performed in 21 (31.8%) patients. Lymph node and distant metastasis was present in 16 (25.0%) and fir (7.8%) patients. The significant risk factors for lymph node metastasis identified in the multivariable analyses were tumor size (≥ 2 cm, p = 0.003) and tumor grade (G2, p < 0.001; G3, p = 0.008). In patients with a tumor smaller than 2 cm, the risk factors for lymph node metastasis included the tumor grade, mitosis count, and Ki-67 index. The median follow-up period was 30.0 months, and recurrence developed in four (6.8%) patients. The significant prognostic factors for survival included tumor size, T stage, lymph node metastasis, and tumor grade. CONCLUSION:Tumor grade combined with tumor size is an important predictive factor for lymph node metastasis and could serve as a prognostic factor for survival outcomes.
Authors: Elizabeth I Harris; David N Lewin; Hanlin L Wang; Gregory Y Lauwers; Amitabh Srivastava; Yu Shyr; Bashar Shakhtour; Frank Revetta; Mary K Washington Journal: Am J Surg Pathol Date: 2008-12 Impact factor: 6.394
Authors: Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier Journal: Pancreas Date: 2010-08 Impact factor: 3.327
Authors: Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew K Stewart Journal: J Clin Oncol Date: 2009-11-30 Impact factor: 44.544
Authors: Katiuscha Merath; Fabio Bagante; Eliza W Beal; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio Rocha; Zaheer Kanji; Sharon Weber; Alexander Fisher; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; Cliff Cho; Megan Beems; Carl R Schmidt; Mary Dillhoff; Shishir K Maithel; Timothy M Pawlik Journal: J Surg Oncol Date: 2018-02-15 Impact factor: 3.454
Authors: Angela Dalia Ricci; Sara Pusceddu; Francesco Panzuto; Fabio Gelsomino; Sara Massironi; Claudio Giovanni De Angelis; Roberta Modica; Gianluca Ricco; Martina Torchio; Maria Rinzivillo; Natalie Prinzi; Felice Rizzi; Giuseppe Lamberti; Davide Campana Journal: J Clin Med Date: 2022-01-28 Impact factor: 4.241